Lynne Gordon, Mph, Cmpp, Bcmas
About Lynne Gordon, Mph, Cmpp, Bcmas
Lynne Gordon, MPH, CMPP, BCMAS, serves as the Director of Publications & Scientific Communications at Travere Therapeutics. With extensive experience in medical affairs and scientific communications across various therapeutic areas, she has held significant roles at multiple pharmaceutical companies, including Abbott Laboratories and Theravance Biopharma.
Work at Travere Therapeutics
Lynne Gordon currently serves as the Director of Publications & Scientific Communications at Travere Therapeutics. She has been in this role since 2023, working remotely from San Diego, California. In her position, she leads efforts to ensure consistent communication of scientific information across various platforms, focusing on the development and refinement of key scientific statements for the company's compounds.
Education and Expertise
Lynne Gordon holds a Master of Public Health (MPH) from the University of Washington and a Bachelor of Science (BS) in Business/Marketing from San Francisco State University. Her educational background supports her extensive expertise in multiple therapeutic areas, including oncology, neurology, infectious diseases, gastroenterology, and respiratory health. She possesses a strong understanding of the phases of clinical development.
Background
Lynne Gordon has a diverse professional background in the pharmaceutical and biotechnology industries. She began her career at Abbott Laboratories, where she held various roles, including Professional Pharmaceutical Representative and Anti-Infective Respiratory Specialist. Over the years, she has worked in multiple capacities at companies such as Enzon Pharmaceuticals, Theravance Biopharma US, Inc., and Aadi Bioscience, Inc.
Achievements
Throughout her career, Lynne Gordon has developed strong relationships with internal colleagues and external key opinion leaders. She has led cross-functional workshops aimed at enhancing scientific communication. Her roles have involved significant contributions to medical affairs operations and scientific publications, particularly in the fields of infectious diseases and oncology.